undamentalytics Newsletter

Kanders Warren B: insider trades

Chief executive, Officer at 2 companies we cover. 5 open-market purchases and 45 sales not made under a pre-set plan, reported from February 24, 2012 to August 26, 2026.

Would copying Kanders Warren B’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 27, 2012 into $12,133 by November 2, 2026, +1.3% a year. The copy held shares only 7% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $14,645, +2.6% a year (the S&P 500 held throughout made $71,166, +14.3% a year). Beta against the index was 0.04. Twelve months after each report, the average purchase was −19.4% against the S&P 500 (median −19.4%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −13.2%. After their sales, the shares moved −10.4% against the index over 12 months on average (a negative figure means selling was the right call); 58% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 20122014201620182020202220242026 $71.2k$14.6k$12.1k
Copying Kanders Warren BS&P 500, same days investedS&P 500, held throughout $10,000 copying Kanders Warren B’s open-market purchases from February 27, 2012, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+1.3%
S&P 500, same days invested
+2.6% (held throughout +14.3%)
Time in shares
7%
Sharpe ratio (S&P 500)
−0.01 (0.79)
Biggest drop (S&P 500)
−27% (−34%)
Market sensitivity (beta)
0.04
Purchases copied
1

Trade by trade

Kanders Warren B: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +10.4% +10.4% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 +6.0% +6.0% 100% 1 — — Not enough years
Purchases, 12 months after the report 1 −19.4% −19.4% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −13.2% −13.2% 0% 1 — — Not enough years
Sales, 3 months after the report 44 −2.2% −1.1% 57% 7 0.46 0.66 No reliable evidence
Sales, 12 months after the report 40 −10.4% −15.9% 58% 6 −0.63 0.55 No reliable evidence
Sales, 12 months after the trade 40 −11.6% −19.9% 55% 6 −0.86 0.43 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cadre Holdings, Inc. CDRE CEO AND CHAIRMAN039December 9, 2022August 26, 2026
Clarus Corp CLAR Executive Chairman56February 24, 2012August 7, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 26, 2026August 24, 2026 CDRE Sale $6,522,601 not yetnot yetnot yet
June 23, 2026June 18, 2026 CDRE Sale $2,068,000 −11.8%not yetnot yet
June 17, 2026June 15, 2026 CDRE Sale $6,539,000 −8.9%not yetnot yet
March 24, 2026March 20, 2026 CDRE Sale $6,333,000 −24.4%not yetnot yet
November 19, 2025November 17, 2025 CDRE Sale $52,413,699 +1.3%not yetnot yet
August 7, 2025August 5, 2025 CLAR Purchase $935,470 not yetnot yetnot yet
June 24, 2025June 23, 2025 CDRE Sale $819,500 +5.7%−31.8%−34.9%
June 24, 2025June 20, 2025 CLAR Purchase $39,689 not yetnot yetnot yet
June 23, 2025June 18, 2025 CDRE Sale $3,348,000 +2.9%−36.0%−43.7%
June 5, 2025June 3, 2025 CDRE Sale $4,200,750 −15.9%−35.9%−37.4%
June 3, 2025May 30, 2025 CDRE Sale $1,637,500 −15.4%−36.2%−37.2%
May 29, 2025May 27, 2025 CDRE Sale $3,290,500 −15.5%−37.2%−32.3%
May 27, 2025May 22, 2025 CDRE Sale $3,292,000 −15.1%−33.7%−35.4%
May 22, 2025May 20, 2025 CDRE Sale $3,486,000 −18.4%−36.1%−40.3%
March 24, 2025March 20, 2025 CDRE Sale $3,143,000 −4.6%−14.5%−17.4%
March 20, 2025March 18, 2025 CDRE Sale $4,783,000 −1.2%−13.8%−18.7%
March 18, 2025March 14, 2025 CDRE Sale $6,624,000 −1.1%−17.4%−21.7%
December 18, 2024December 16, 2024 CDRE Sale $439,457 −11.0%+0.4%+0.5%
December 16, 2024December 13, 2024 CDRE Sale $882,250 −6.5%+3.4%+3.5%
December 13, 2024December 11, 2024 CDRE Sale $883,000 −5.6%+0.5%+5.0%
December 11, 2024December 9, 2024 CDRE Sale $1,763,500 −2.6%+4.2%+9.1%
December 9, 2024December 5, 2024 CDRE Sale $1,787,500 +2.9%+11.8%+7.6%
December 4, 2024December 2, 2024 CDRE Sale $2,587,144 +1.8%+7.6%+14.7%
December 2, 2024November 27, 2024 CDRE Sale $1,658,233 +2.6%+9.9%+14.4%
November 27, 2024November 26, 2024 CDRE Sale $1,677,500 +1.4%+14.9%+12.7%
November 25, 2024November 21, 2024 CDRE Sale $3,301,000 −0.7%+12.7%+16.0%
November 21, 2024November 19, 2024 CDRE Sale $2,152,402 +0.4%+14.5%+14.3%
November 19, 2024November 15, 2024 CDRE Sale $1,889,565 +2.1%+12.6%+9.8%
September 13, 2024September 11, 2024 CLAR Purchase $79,304 not yetnot yetnot yet
September 11, 2024September 9, 2024 CDRE Sale $7,305,664 −6.9%−24.3%−24.9%
September 10, 2024September 6, 2024 CLAR Purchase $1,159,500 not yetnot yetnot yet
March 20, 2024March 19, 2024 CDRE Sale $50,334,445 −15.0%−21.2%−21.1%
December 11, 2023December 7, 2023 CDRE Sale $620,965 −1.1%−20.3%−24.1%
December 7, 2023December 5, 2023 CDRE Sale $634,608 +9.3%−22.9%−25.6%
December 5, 2023December 1, 2023 CDRE Sale $626,346 +5.7%−25.0%−26.2%
December 1, 2023November 29, 2023 CDRE Sale $625,577 +0.2%−27.7%−30.0%
November 29, 2023November 27, 2023 CDRE Sale $620,196 +2.5%−26.7%−30.2%
November 27, 2023November 22, 2023 CDRE Sale $477,061 −0.1%−28.3%−26.9%
November 22, 2023November 20, 2023 CDRE Sale $442,190 +3.4%−26.3%−29.4%
June 8, 2023June 8, 2023 CDRE Sale $32,775,000 +23.0%+43.1%+38.8%
December 28, 2022December 23, 2022 CDRE Sale $530,574 +1.6%+39.8%+37.6%
December 14, 2022December 12, 2022 CDRE Sale $425,884 −15.1%+26.0%+31.3%
December 9, 2022December 7, 2022 CDRE Sale $599,942 −8.4%+31.3%+22.0%
June 1, 2022May 31, 2022 CLAR Sale $550,250 −22.5%−66.1%−67.4%
May 27, 2022May 25, 2022 CLAR Sale $10,227,250 −21.4%−67.4%−64.9%
March 15, 2022March 11, 2022 CLAR Sale $1,800,755 −5.6%−52.8%−52.9%
March 22, 2021March 18, 2021 CLAR Sale $1,935,005 +46.3%+33.4%+25.4%
March 15, 2021March 11, 2021 CLAR Sale $1,496,506 +30.4%+23.8%+17.7%
January 31, 2019January 29, 2019 CLAR Sale $15,162,000 +16.0%−2.6%+0.2%
February 24, 2012February 12, 2012 CLAR Purchase $5,000,002 +10.4%−19.4%−13.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Kanders Warren B traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.